| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027743769 |
| P356 | DOI | 10.1245/S10434-011-1984-9 |
| P8608 | Fatcat ID | release_rqngjo3n4bek7pwekvrc2ubqq4 |
| P698 | PubMed publication ID | 21837528 |
| P5875 | ResearchGate publication ID | 51567507 |
| P50 | author | Ignace Hjt de Hingh | Q56999746 |
| Roger M. Lomme | Q73775323 | ||
| Robert P. Bleichrodt | Q130279514 | ||
| Thijs Hendriks | Q130279523 | ||
| P2093 | author name string | Harm J T Rutten | |
| Yvonne L B Klaver | |||
| P2860 | cites work | The cellular and molecular basis of hyperthermia | Q34721242 |
| Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment | Q36336662 | ||
| Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. | Q39556650 | ||
| Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model. | Q39661421 | ||
| Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model | Q40404008 | ||
| Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. | Q40698258 | ||
| A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. | Q42609788 | ||
| Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine? | Q43201545 | ||
| Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin | Q44097797 | ||
| Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study | Q44393228 | ||
| The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. | Q46422975 | ||
| Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis | Q46938764 | ||
| Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors. | Q50518842 | ||
| Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
| P921 | main subject | chemotherapy | Q974135 |
| peritoneal carcinomatosis | Q2071182 | ||
| P304 | page(s) | S475-82 | |
| P577 | publication date | 2011-08-12 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study | |
| P478 | volume | 19 Suppl 3 |
| Q64240258 | Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization |
| Q37308110 | Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol |
| Q38728196 | Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? |
| Q39310531 | Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial? |
| Q37722146 | Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study |
| Q38152303 | Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models |
| Q55135995 | Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. |
| Q42398293 | Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. |
| Q92617837 | Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS) |
| Q37071401 | Safe temperature range for intraoperative and early postoperative continuous hyperthermic intraperitoneal perfusion in a swine model of experimental distal gastrectomy with Billroth II reconstruction |
| Q44199166 | Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction |
| Q92432508 | Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study |
Search more.